Dozens of drugs, both prescription and illicit, can cause the heart to enlarge by damaging or overstressing its muscle. The medical term for this is drug-induced cardiomyopathy, and it spans a surprisingly wide range of substances: cancer chemotherapy agents, street stimulants, alcohol, anabolic steroids, certain psychiatric medications, and even some herbal supplements. In many cases the enlargement develops slowly over months or years of use, making it easy to miss until symptoms like breathlessness or fatigue set in. The specific way each drug harms the heart varies, but the outcome is often the same: a weakened, stretched-out pump that struggles to move blood efficiently.
Cancer Chemotherapy Drugs
Chemotherapy agents are among the best-studied causes of drug-induced heart enlargement. Doxorubicin, one of the most widely used cancer drugs for decades, is the textbook example. It belongs to a class called anthracyclines and causes heart damage in a way that is clearly tied to how much of the drug a patient receives over time. A retrospective analysis of three clinical trials estimated that roughly a quarter of patients who reached a high cumulative dose developed heart failure related to the drug.1PubMed. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials That risk is why oncologists carefully track every milligram given and often set lifetime dose limits. The damage stems from the drug’s effect on the heart cells’ energy-producing machinery, which can weaken and stretch the heart chambers over time.2PubMed. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy
Newer targeted cancer therapies carry cardiac risks too, though the patterns differ from traditional chemotherapy. Sunitinib, a drug used for kidney cancer and certain gastrointestinal tumors, was shown in one study to cause meaningful drops in heart pumping function in close to a third of patients treated at the standard dose.3PubMed Central. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib Other targeted therapies like trastuzumab (used in breast cancer), bevacizumab, and imatinib have also been linked to heart dysfunction, including reduced pumping ability and heart failure.4PubMed Central. Cardiotoxicity associated with targeted cancer therapies One important difference with trastuzumab: its heart effects are generally considered more reversible than those caused by anthracyclines, especially when caught early. For patients on these drugs, regular monitoring of heart function is standard practice.
Immune Checkpoint Inhibitors
A newer class of cancer drugs called immune checkpoint inhibitors has introduced a different kind of cardiac threat. These drugs work by releasing the brakes on the immune system so it can attack tumors more aggressively, but sometimes the unleashed immune response turns on the heart itself. The result is myocarditis, an inflammation of the heart muscle that can be severe and even fatal. The risk is highest when two checkpoint inhibitors are combined, and the damage is driven by immune cells, particularly T cells and macrophages, infiltrating the heart muscle.5Circulation. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis This is a fundamentally different mechanism from what doxorubicin does. Rather than poisoning heart cells directly, these drugs trigger the body’s own defenses to attack them. The inflammation can cause the heart to swell and weaken if not caught and treated quickly, typically by stopping the drug and using immunosuppressive therapy.
Cocaine and Methamphetamine
Illicit stimulants are major contributors to heart enlargement, particularly in younger adults who might not otherwise be at risk for heart disease. Cocaine affects the heart in a distinctive way: chronic use has been linked to increased heart weight and thickened ventricular walls, a pattern called concentric hypertrophy, where the muscle thickens inward rather than the chambers stretching outward.6Scientific Reports. Cocaine, cardiomyopathy, and heart failure: a systematic review and meta-analysis Over time, those stiffened walls make it harder for the heart to relax and fill properly between beats. Cocaine also constricts blood vessels and can trigger dangerous spikes in blood pressure, compounding the strain.
Methamphetamine, by contrast, tends to cause a more classic pattern of heart enlargement where the chambers dilate and the muscle weakens, sometimes dramatically. In one study of patients with methamphetamine-associated cardiomyopathy, average heart pumping function had fallen to about 20% at the time of diagnosis, far below the normal range of 55 to 70%.7PubMed. Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery Some of those patients were so sick they needed mechanical heart support. The encouraging part is that for some people, stopping methamphetamine and starting heart failure treatment can lead to significant recovery. One case report documented a patient with severe methamphetamine cardiomyopathy whose heart function recovered after six months of abstinence and medical therapy.8PubMed Central. Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance That potential for recovery makes early detection and drug cessation particularly important.
Alcohol
Alcohol is the most common legal substance linked to an enlarged heart, though the relationship is messier than it might seem. Alcoholic cardiomyopathy is a recognized condition in which long-term heavy drinking leads to a dilated, weakened heart. The chamber walls stretch and thin, pumping efficiency drops, and fluid can back up into the lungs.9PubMed Central. Alcoholic cardiomyopathy What makes this tricky is that not everyone who drinks heavily develops it, and the exact amount and duration of drinking that tips someone over the edge varies considerably from person to person. There are likely genetic factors at play that make some people’s hearts more vulnerable to alcohol than others.
The evidence base linking alcohol to cardiomyopathy actually comes largely from case series of patients already diagnosed with a dilated heart, many of whom reported histories of very heavy drinking.10PubMed. Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy That makes it hard to draw a neat dose-response curve the way researchers can with, say, doxorubicin. Still, the clinical consensus is clear enough: chronic heavy alcohol use can enlarge and damage the heart, and reducing or eliminating alcohol is a key part of treatment when it is identified as the cause. Like methamphetamine cardiomyopathy, some degree of recovery is possible if the person stops drinking and receives appropriate heart failure therapy, though the heart may not return to normal entirely.
Anabolic Steroids
Performance-enhancing anabolic steroids are an underappreciated cause of heart enlargement, partly because the people using them tend to be young and appear outwardly healthy. Case reports have documented dilated cardiomyopathy in young men with no other cardiac risk factors whose only identifiable exposure was prolonged steroid abuse.11PubMed Central. Building Body With Anabolics Is Weakening the Heart: Anabolic Steroid Induced Cardiomyopathy The exact way steroids damage the heart is not fully worked out, but the combination of elevated blood pressure, increased blood volume, direct effects on heart muscle cells, and hormonal disruption all likely play a role. Because steroid users often take multiple substances at high doses for extended periods without medical supervision, the damage can accumulate unnoticed. By the time shortness of breath or exercise intolerance brings someone to a doctor, the heart may already be significantly enlarged.
Prescription Psychiatric and Stimulant Medications
Clozapine, an antipsychotic used for treatment-resistant schizophrenia, stands out among psychiatric medications for its association with serious cardiac side effects. It can cause both myocarditis (inflammation of the heart muscle) and dilated cardiomyopathy.12PubMed. Clozapine and cardiotoxicity – A guide for psychiatrists written by cardiologists The overall risk is low, estimated at less than 1% for myocarditis occurring within the first two months and roughly ten times less for cardiomyopathy developing over the following months.13PubMed. Systematic Review of Clozapine Cardiotoxicity But “low” is cold comfort when the consequences can be fatal, which is why patients starting clozapine typically undergo cardiac monitoring during the early weeks of treatment. The challenge for clinicians is that clozapine is often the only medication that works for the most severely ill patients, creating a difficult risk-benefit calculation.
Prescription stimulants used for ADHD, such as amphetamine-dextroamphetamine combinations, also warrant attention. These medications reliably raise resting heart rate and blood pressure, and there have been reports of cardiomyopathy in patients using them long term.14PubMed. Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week Chronic amphetamine exposure may contribute to heart damage through increased oxidative stress, overactivation of the sympathetic nervous system, and direct toxicity to heart muscle cells.15PubMed Central. Prolonged Amphetamine-Dextroamphetamine Use: An Unrecognized Cause of Cardiomyopathy It is worth noting that population-level studies have not definitively shown a causal link between therapeutic-dose ADHD stimulants and cardiomyopathy, and there is limited randomized trial data on their long-term cardiac safety in adults.14PubMed. Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week The current picture is that the risk is likely small at standard doses but may increase with prolonged use, higher doses, or in people with preexisting cardiac vulnerability.
HIV Antiretroviral Drugs and Other Medications
Several other medication classes have been implicated in heart muscle damage through their effects on the energy-producing structures inside heart cells. Certain antiretroviral drugs used to treat HIV, for example, can interfere with the machinery that copies mitochondrial DNA, disrupting the heart cell’s ability to generate energy. They have also been shown to interfere with the normal cycle by which mitochondria divide and fuse, further impairing their function.16Cell Reports Medicine. Toward a broader view of mechanisms of drug cardiotoxicity Older antiretroviral regimens were more prone to this than current ones, and modern HIV treatment guidelines take cardiac risk into account when selecting drugs.
Growth hormone excess, whether from a pituitary tumor or from exogenous use (as sometimes seen in bodybuilding), can also lead to heart enlargement. The resulting condition typically presents with enlargement of both ventricles and problems with the heart’s ability to relax between beats. The degree of cardiac damage is tied more closely to how long the hormone excess persists than to how high the levels actually climb.17PubMed Central. Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat? This means that people who use growth hormone for years are at greater risk than those with brief exposures, regardless of dose.
Herbal Products and Supplements
Herbal medicines occupy a blind spot in many people’s thinking about heart risk. Because they are sold as “natural,” users and even some healthcare providers may not consider them as potential causes of cardiac damage. But a systematic review of the literature found that herbal products have been linked to serious cardiovascular effects including heart failure, dangerous heart rhythms, and chest pain. The herbs most frequently implicated include aconite, ephedra, and licorice.18PubMed. Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature Problems arise from toxic ingredients in the herbs themselves, contamination or adulteration of the product with unlisted substances, and interactions between the herbs and prescription drugs a person may already be taking. Ephedra-containing products, once widely used for weight loss and athletic performance, were banned by the FDA in 2004 partly because of their cardiac risks, though ephedra-containing supplements can still be obtained through some channels.
How These Drugs Damage the Heart
The mechanisms behind drug-induced heart enlargement are varied, but a few common threads run through many of them. One of the most important is mitochondrial damage. Mitochondria are the tiny power plants inside each heart cell, and the heart, which never stops working, is extraordinarily dependent on them. When drugs interfere with mitochondrial function, the heart cell loses its energy supply, weakens, and eventually dies.19PubMed Central. Drug-induced mitochondrial dysfunction and cardiotoxicity This is the primary pathway for anthracycline chemotherapy drugs, antiretrovirals, and even some local anesthetics.16Cell Reports Medicine. Toward a broader view of mechanisms of drug cardiotoxicity
Beyond mitochondrial damage, drugs can kill heart cells through multiple other pathways. These include triggering programmed cell death, overwhelming the cell’s recycling processes, and causing uncontrolled inflammatory cell death.20PubMed Central. Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity Stimulants like cocaine and methamphetamine add a different layer: they flood the body with stress hormones, force the heart to beat faster and harder, and constrict the blood vessels the heart needs to feed itself. Over time, that combination remodels the heart in harmful ways. The end result, whether the damage comes from a cancer drug, a street drug, or a psychiatric medication, is a heart that is bigger than it should be and weaker than it needs to be.
Catching It Early
One of the frustrating aspects of drug-induced heart enlargement is that it often causes no symptoms until the damage is well advanced. A person may feel fine while their heart is quietly remodeling. This is why patients on known cardiotoxic drugs like anthracyclines undergo scheduled heart imaging, typically echocardiograms, to measure how well the heart is pumping. A prospective study of chemotherapy patients found that after one year of treatment, essentially all patients showed some degree of impaired heart relaxation, but in about a third, the abnormality could only be picked up with more sensitive imaging techniques rather than standard measurements.21PubMed. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study That finding highlights the gap between what routine screening catches and what more advanced tools can detect.
For people using illicit drugs or non-prescription substances, this monitoring rarely happens. Someone using methamphetamine or anabolic steroids is unlikely to be getting regular echocardiograms. Warning signs to watch for include unexplained shortness of breath (especially when lying flat or during exertion that was previously easy), swelling in the ankles and legs, persistent fatigue, and a rapid or irregular heartbeat. Any of these in someone with a history of drug use should prompt a medical evaluation.
When Stopping the Drug Helps, and When It Does Not
Whether drug-induced heart enlargement can be reversed depends heavily on what caused it, how long the exposure lasted, and how much damage has already been done. As mentioned earlier, methamphetamine cardiomyopathy can improve substantially if the person stops using and receives treatment. The same applies to alcoholic cardiomyopathy. Heart damage from trastuzumab is generally considered more reversible than that from anthracyclines, where the injury to heart cells is often permanent.
A small but notable trial tested what happens when patients whose dilated cardiomyopathy had apparently recovered are taken off their heart failure medications. The results were sobering: among those who stopped treatment, many experienced a return of heart dysfunction, and all who deteriorated were put back on medication. At follow-up after restarting drugs, the large majority recovered again, with pumping function returning above 50%.22The Lancet. Withdrawal of existing pharmacological therapy for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): a randomised, open-label pilot trial The practical takeaway is that even when the heart appears to have recovered from drug-induced damage, the underlying vulnerability may remain. Stopping heart failure medications prematurely, even when you feel fine, can be risky.
Cobalt and Historical Lessons
One of the more unusual chapters in the history of drug-induced heart disease involves cobalt. In the 1960s, breweries in certain regions added cobalt to beer as a foam stabilizer. Clusters of heavy beer drinkers subsequently developed fatal heart failure in what became known as beer-drinker’s cardiomyopathy. Later, occupational exposure to cobalt in metal refining was found to cause direct damage to the heart muscle. More recently, cobalt-induced cardiomyopathy has resurfaced as a complication of certain metal-on-metal hip replacements that slowly release cobalt ions into the bloodstream.23PubMed Central. Cobalt-Induced Cardiomyopathy: Mitochondrial Dysfunction, Oxidative Stress, and Reversible Cardiac Toxicity: A Systematic Review The cobalt story is a useful reminder that cardiac toxicity can come from unexpected sources and that vigilance needs to extend beyond the pharmacy. Any substance that reaches the bloodstream at sufficient concentration and for long enough has the potential to harm the heart, whether it arrives via a pill bottle, a syringe, a pint glass, or a hip implant.